For following the competition: what moved in each program, several studies read as one move.
- Alveltamig
- nilvanstomig
- Anti-PD-L1/4-1BB Bispecific Antibody LBL-024
- + 10 more
Mondays · ranked, phase 3 first · readouts ahead · See a sample brief
Add Carcinoma, Neuroendocrine to watchlistEvery Monday by email · turn it off any timePro · free during the beta